دورية أكاديمية

Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

التفاصيل البيبلوغرافية
العنوان: Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
المؤلفون: Swanson, Chad J., Zhang, Yong, Dhadda, Shobha, Wang, Jinping, Kaplow, June, Lai, Robert Y. K., Lannfelt, LarsAff3, Aff4, Bradley, Heather, Rabe, Martin, Koyama, Akihiko, Reyderman, Larisa, Berry, Donald A., Berry, Scott, Gordon, Robert, Kramer, Lynn D., Cummings, Jeffrey L.Aff6, IDs13195022009959_cor16
المصدر: Alzheimer's Research & Therapy. 14(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:17589193
DOI:10.1186/s13195-022-00995-9